Skip to content

Mastectomy With Retention of the Nipple-areola Complex, Robot-assisted or Not, and / or Immediate or Seconday Reconstruction by Latissimus Dorsi Flap, Robot-assisted or Not.

Mastectomy With Retention of the Nipple-areola Complex, Robot-assisted or Not, and / or Immediate or Secondary Reconstruction by Latissimus Dorsi Flap, Robot-assisted or Not.

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04457167
Acronym
RMR
Enrollment
480
Registered
2020-07-07
Start date
2020-11-01
Completion date
2026-11-01
Last updated
2020-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Reconstruction, Mastectomy

Keywords

robot-assisted, mini-invasive surgery

Brief summary

Phase III, non-randomized, monocentric, observational, prospective trial. It is planned to recruit a total of 480 patients, including 240 patients receiving mastectomy with preservation of the nipple-areola complex and 240 patients with a reconstruction with latissimus dorsi flap, or in immediate reconstruction, or during secondary reconstruction.

Detailed description

Phase III, non-randomized, monocentric, observational, prospective trial. It is planned to recruit a total of 480 patients, including 240 patients receiving mastectomy with preservation of the nipple-areola complex and 240 patients with a reconstruction with latissimus dorsi flap, or in immediate reconstruction, or during secondary reconstruction.

Interventions

robot-assisted surgery

PROCEDURENot robot-assisted surgery

Not robot-assisted surgery

Sponsors

Institut Paoli-Calmettes
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Phase III, non-randomized, monocentric, observational, prospective trial.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age ≥ 18 years old, 2. Signed consent to participate, 3. Women with breast cancer over 18 or at high risk of breast cancer (BRCA 1-2 mutations, PALB2, extensive border lesions) 4. Mastectomy with conservation of the areolo-mammary plaque, or mastectomy without conservation of the areolo-mammary plaque and conservation of the skin case 5. Mastectomy without conservation of the areolo-mammary plate, immediate breast reconstruction by prosthesis, 6. immediate breast reconstruction by autologous latissimus dorsi flap 7. immediate breast reconstruction by latissimus dorsi flap and prosthesis, 8. secondary breast reconstruction by latissimus dorsi flap 9. Affiliation to, or beneficiary of, a social security scheme.

Exclusion criteria

1. Patient under 18, 2. Pregnant woman or likely to be (without effective contraception) or breastfeeding, 3. Person in emergency situation, adult person subject to a legal protection measure (adult under guardianship, curatorship or safeguard of justice), or out of state to express his consent, 4. Inability to submit to medical follow-up for the trial for geographic, social or psychological reasons.

Design outcomes

Primary

MeasureTime frameDescription
rate of postoperative early complications90 daysTo assess the value of robotic surgery for breast mastectomy with preservation of the nipple-areola complex and immediate or delayed reconstruction by latissimus dorsi flap, with an evaluation of the rate of postoperative early complications (90 postoperative days)

Countries

France

Contacts

Primary ContactDominique Genre
DRCI.UP@ipc.unicancer.fr33491223778
Backup ContactMargot Berline
DRCI.UP@ipc.unicancer.fr33491223778

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026